Abstract
The purpose of this study was to evaluate whether avoiding interruption of ventilation during surfactant instillation improves the effects on lung function and surfactant distribution and whether it prevents the adverse effects on blood pressure and cerebral blood flow. The study was performed using rabbits with severe respiratory failure induced by lung lavages. These rabbits were randomized to 99mTc-Nanocoll labeled surfactant instillation through a side lumen of the endotracheal tube without interrupting ventilation or instillation during a short interruption of ventilation. After surfactant instillation with interruption of ventilation, PaO2 rose from 8.7 ± 1.3 to 24.9 ± 6.4 kPa (mean ± SEM). Without interruption, PaO2 rose from 8.4 ± 0.8 to 32.4 ± 4.3 kPa. PaCO2 decreased with interruption from 4.69 ± to 3.61 ± 0.26 kPa and without interruption from 5.06 ± 0.41 to 4.13 ± 0.23 kPa. Dynamic and static compliance indices were not statistically different after both procedures. Surfactant distribution tended to be less nonuniform after instillation without interrupting ventilation. In contrast, avoidance of interruption of ventilation resulted in less uniform lobar distribution and less peripheral deposition of surfactant. By instillation with interruption, blood pressure increased quickly (28 ± 6.6%), followed by a 22 ± 5.3% decrease. Blood pressure increased quickly (16 ± 4.2%), followed by a 40 ± 10% decrease by surfactant instillation without interruption. Cerebral blood flow, measured by an ultrasonic transit time flow probe on the carotid artery, increased quickly (45 ± 14%), followed by a 64 ± 11% decrease with interruption, whereas it increased 15 ± 4.9% (p = 0.06 versus with interruption) and decreased 61 ± 13% without interruption of ventilation. Therefore, avoiding interruption of ventilation during surfactant instillation tends to prevent the potential adverse effects of a rapid rise in cerebral blood flow, and furthermore, tends to improve uniformity of surfactant distribution, whereas having no detrimental effect on respiratory function.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- MABP:
-
mean arterial blood pressure
- CBF:
-
cerebral blood flow
- RDS:
-
respiratory distress syndrome
- BW:
-
body weight
- PEEP:
-
positive end-expiratory pressure
- FiO2:
-
fractional inspired oxygen
- CPAP:
-
continuous positive airway pressure
- PaO2:
-
partial arterial oxygen tension
- PaCO2:
-
partial arterial carbon dioxide tension
References
Soll RF, Merritt TA, Hallman M 1994 Surfactant in the prevention and treatment of respiratory distress syndrome. In: Boynton BR (ed) New Therapies for Neonatal Respiratory Failure. Cambridge University Press, New York, 49–80.
Mercier CE, Soll RF 1993 Clinical trials of natural surfactant extracts in respiratory distress syndrome. Clin Perinatol 20: 711–735
Charnan A, Taeusch W, Fitzgibbon C, Smith GB, Treves ST, Phelps D 1989 Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics 83: 348–354
Wells JT, Ment LR 1995 Prevention of intraventricular hemorrhage in preterm infants. Early Hum Dev 42: 209–233
Skinner J 1997 The effects of surfactant on haemodynamics in hyaline membrane disease. Arch Dis Child 76: F67–F69
Skov L, Hellström-Westas L, Jacobsen T, Greisen G, Svenningsen NW 1991 Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment. Neuropediatrics 23: 126–130
Hellström-Westas L, Bell AH, Skov L, Greisen G, Svenningsen NW 1992 Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics 89: 643–647
van de Bor M, Ma EJ, Walther FJ 1991 Cerebral blood flow velocity after surfactant instillation in preterm infants. J Pediatr 118: 285–287
van Bel F, de Winter PJ, Wijnands HBG, van de Bor M, Egberts J 1992 Cerebral and aortic blood flow velocity patterns in preterm infants receiving prophylactic surfactant treatment. Acta Paediatr Scand 81: 504–510
Cowan F, Whitelaw A, Wertheim D, Silverman M 1991 Cerebral blood flow velocity changes after rapid administration of surfactant. Arch Dis Child 66: 1105–1109
Saliba E, Nashashibi M, Vaillant MC, Nasr C, Laugier J 1994 Instillation rate effects of Exosurf on cerebral and cardiovascular hemodynamics in preterm neonates. Arch Dis Child 71: F174–F178
Gunkel HJ, Banks PL 1993 Surfactant treatment and intracranial hemorrhage: review of the literature and result of new analyses. Pediatrics 92: 775–786
Vohr B, Ment LR 1996 Intraventricular hemorrhage in the preterm infant. Early Hum Dev 44: 1–16
Jobe AH, Ikegami M, Jacobs H, Jones S 1984 Surfactant and pulmonary blood flow distributions following the treatment of premature lambs with natural surfactant. J Clin Invest 73: 848–856
van der Bleek J, Plotz FB, Overbeek FM, Heikamp A, Beekhuis H, Wildevuur RH, Okken A, Bambang Oetomo S 1993 Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume. Pediatr Res 34: 154–158
Gilliard N, Richman PM, Merritt TA, Spragg RG 1990 Effects of volume and dose on the pulmonary distribution of exogenous surfactant administration to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Respir Dis 141: 743–747
Alvarez FJ, Alfonso LF, Fastiasoro E, Lopez-Heredia J, Arnaiz A, Valls-i-Soler A 1995 The effects of multiple small doses of exogenous surfactant on experimental respiratory failure induced by lung lavage in rats. Acta Anaesthesiol Scand 39: 970–974
Ueda T, Ikegami M, Rider ER, Jobe AH 1994 Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 76: 45–55
Segerer H, van Gelder W, Angenent FWM, van Woerkens LJ, Curstedt T, Obladen M, Lachmann B 1993 Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by instillation technique. Pediatr Res 34: 490–494
Lewis JF, Ikegami M, Jobe AH, Tabor B 1991 Aerosolized surfactant treatment of preterm lambs. J Appl Physiol 70: 869–876
Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D 1993 Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 74: 1256–1264
Lewis JF, Ikegami M, Jobe AH, Absolom D 1993 Physiologic responses and distribution of aerosolized surfactant (Survanta) in a non-uniform pattern of lung injury. Am Rev Respir Dis 147: 1364–1370
Li WZ, Chen WM, Kobayashi T 1994 Aerosolized surfactant reverses respiratory failure in lung-lavaged rats. Acta Anaesthesiol Scand 38: 82–88
Henry MD, Rebello CM, Ikegami M, Jobe AH, Langenback EG, Davis JM 1996 Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs. Am J Respir Crit Care Med 154: 366–375
Dijk PH, Heikamp A, Bambang Oetomo S 1997 Surfactant nebulization prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure. Intensive Care Med 23: 1077–1081
Dijk PH, Heikamp A, Bambang Oetomo S 1997 Surfactant nebulization: lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits. Intensive Care Med 23: 1070–1076
Dijk PH, Heikamp A, Piers DA, Weller E, Bambang Oetomo S 1997 Surfactant nebulization: safety, efficiency and influence on surface lowering properties and biochemical composition. Intensive Care Med 23: 456–462
Bambang Oetomo S, Reijngoud DJ, Ennema JJ, Okken A, Wildevuur CRH 1988 Surfactant replacement therapy in surfactant deficient rabbits: early effects, lung function, and biochemical aspects. Lung 166: 65–73
Lachmann B, Robertson B, Vogel J 1980 In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 24: 231–236
Gruenwald PA 1962 A numerical index of the stability of lung expansion. J Appl Physiol 18: 645–667
Clements JA, Hustead F, Johnson RP, Gribetz J 1961 Pulmonary surface tension and alveolar stability. J Appl Physiol 16: 444–450
Merritt TA, Kheiter A, Cochrane CG 1995 Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatr Res 38: 211–217
Davis JM, Russ GA, Metlay L, Dickerson B, Greenspan BS 1992 Short term distribution kinetics of intratracheally administered exogenous surfactant. Pediatr Res 31: 445–450
Espinosa FF, Shapiro AH, Fredberg JJ, Kamm RD 1993 Spreading of exogenous surfactant in an airway. J Appl Physiol 75: 2028–2039
Edwards AD, McCormick DC, Roths SC, Peebles DM, Cope M, Wyatt JS, Delphy DT, Reynolds EOR 1992 Cerebral hemodynamic effects of treatment with modified natural surfactant investigated by near infrared spectroscopy. Pediatr Res 32: 532–536
Pryds O, Edwards AD 1996 Cerebral blood flow in the newborn infants. Arch Dis Child 74: F63–F69
Seidner SR, Ikegami M, Yamada T, Rider ED, Castro R, Jobe AH 1995 Decreased surfactant dose-response after delayed administration to preterm rabbits. Am J Respir Crit Care Med 152: 113–120
Author information
Authors and Affiliations
Additional information
This study was supported by a research grant from Thomae GmbH, Biberach an der Riss, Germany.
Rights and permissions
About this article
Cite this article
Dijk, P., Heikamp, A. & Oetomo, S. A Comparison of the Hemodynamic and Respiratory Effects of Surfactant Instillation during Interrupted Ventilation versus Noninterrupted Ventilation in Rabbits with Severe Respiratory Failure. Pediatr Res 45, 235–241 (1999). https://doi.org/10.1203/00006450-199902000-00013
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199902000-00013
